Elizabet C. Jusuf, Karloman A. Paipinan
Background: Nuchal translucency (NT) measurement is widely used in prenatal screening to detect chromosomal abnormalities, but its role in identifying congenital defect remains variably reported. Congenital heart disease (CHD) refers to structural malformations of the heart and/or great vessels, which predispose affected individuals to multiple morbidities across their lifespan and contribute to reduced long-term survival.. Although numerous studies have evaluated NT, none have specifically summarized…